Raymond James Downgrades Pharmaceutical Product Development (PPDI) to Market Perform
Tweet
Share
E-mailGet Alerts PPDI Hot Sheet
Price: $33.24 --0%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Raymond James downgraded Pharmaceutical Product Development (NASDAQ: PPDI) from Outperform to Market Perform.
For more ratings news on Pharmaceutical Product Development click here and for the rating history of Pharmaceutical Product Development click here.
Shares of Pharmaceutical Product Development closed at $31.15 yesterday.
For more ratings news on Pharmaceutical Product Development click here and for the rating history of Pharmaceutical Product Development click here.
Shares of Pharmaceutical Product Development closed at $31.15 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- HSBC Downgrades Cisco (CSCO) to Hold
- Desjardins Downgrades Alithya Group Inc. (ALYA:CN) (ALYA) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
